Technology Networks: Protein blueprint could help to develop infertility treatments
Research from a UC College of Medicine laboratory is featured in science news service
UC Professor Thomas Thompson, PhD, and Kaitlin Hart, a doctoral student, are advancing our understanding of the protein anti-Müllerian hormone hormone (AMH), which helps form male reproductive organs and in females regulates follicle development and ovulation in the ovaries. They have developed a blueprint for how AMH operates and their findings are available online in the scholarly journal for the Proceedings of the National Academy of Sciences (PNAS). Knowledge of AMH may assist researchers in finding treatments for infertility in women.
Read the story in Technology Networks.
This story was also covered in the online publication Babygaga.
Learn more about Thomas Thompson, PhD, professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology.
Featured image of hormone molecule taken by Colleen Kelley/UC Creative + Brand.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.